NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,725 | +16.6% | 47,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $59,808 | -45.6% | 47,000 | -42.7% | 0.00% | -50.0% |
| Q1 2023 | $110,003 | +71797.4% | 82,000 | -15.5% | 0.00% | -33.3% |
| Q4 2022 | $153 | -99.8% | 97,000 | +42.6% | 0.01% | +50.0% |
| Q3 2022 | $95,000 | -40.6% | 68,000 | -41.4% | 0.00% | -50.0% |
| Q3 2020 | $160,000 | -17.1% | 116,000 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $193,000 | +175.7% | 116,000 | +110.9% | 0.01% | +150.0% |
| Q1 2020 | $70,000 | -45.7% | 55,000 | -34.5% | 0.00% | -33.3% |
| Q4 2019 | $129,000 | +11.2% | 84,000 | -1.2% | 0.01% | 0.0% |
| Q3 2019 | $116,000 | – | 85,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |